A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Methyprylon
Siltuximab
The risk or severity of adverse effects can be increased when Belinostat is combined with Siltuximab.
Methyprylon
Secukinumab
The risk or severity of adverse effects can be increased when Belinostat is combined with Secukinumab.
Methyprylon
Fluprednidene
The risk or severity of adverse effects can be increased when Belinostat is combined with Fluprednidene.
Methyprylon
Fluticasone furoate
The risk or severity of adverse effects can be increased when Belinostat is combined with Fluticasone furoate.
Methyprylon
Certolizumab pegol
The risk or severity of adverse effects can be increased when Belinostat is combined with Certolizumab pegol.
Methyprylon
Brentuximab vedotin
The risk or severity of adverse effects can be increased when Belinostat is combined with Brentuximab vedotin.
Methyprylon
Golimumab
The risk or severity of adverse effects can be increased when Belinostat is combined with Golimumab.
Methyprylon
Bosutinib
The risk or severity of adverse effects can be increased when Belinostat is combined with Bosutinib.
Methyprylon
Rilonacept
The risk or severity of adverse effects can be increased when Belinostat is combined with Rilonacept.
Methyprylon
Tocilizumab
The risk or severity of adverse effects can be increased when Belinostat is combined with Tocilizumab.
Methyprylon
Canakinumab
The risk or severity of adverse effects can be increased when Belinostat is combined with Canakinumab.
Methyprylon
Trastuzumab emtansine
The risk or severity of adverse effects can be increased when Belinostat is combined with Trastuzumab emtansine.
Methyprylon
Apremilast
The risk or severity of adverse effects can be increased when Belinostat is combined with Apremilast.
Methyprylon
Trabectedin
The risk or severity of adverse effects can be increased when Belinostat is combined with Trabectedin.
Methyprylon
Afelimomab
The risk or severity of adverse effects can be increased when Afelimomab is combined with Belinostat.
Methyprylon
Paramethasone
The risk or severity of adverse effects can be increased when Paramethasone is combined with Belinostat.
Methyprylon
Cortisone acetate
The risk or severity of adverse effects can be increased when Cortisone acetate is combined with Belinostat.
Methyprylon
Corticotropin
The risk or severity of adverse effects can be increased when Corticotropin is combined with Belinostat.
Methyprylon
Abatacept
The risk or severity of adverse effects can be increased when Abatacept is combined with Belinostat.
Methyprylon
Ifosfamide
The risk or severity of adverse effects can be increased when Ifosfamide is combined with Belinostat.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3